ONKURE THERAPEUTICS, INC. (OKUR) Operating income 2020–2025
ONKURE THERAPEUTICS, INC. (OKUR) annual operating income history from SEC filings — each fiscal year as reported.
-$63.0MFY2025 · since FY2020: -$19.6M → -$63.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.0M | -15.7% |
| FY2024 | -$54.4M | -47.3% |
| FY2023 | -$36.9M | +31.4% |
| FY2022 | -$53.8M | -35.2% |
| FY2021 | -$39.8M | -103.7% |
| FY2020 | -$19.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OKUR financial trends
OKUR RevenueOKUR Net incomeOKUR Net marginOKUR Gross profitOKUR Gross marginOKUR Operating marginOKUR Operating cash flowOKUR Free cash flowOKUR Capital expendituresOKUR Return on equityOKUR Stock buybacksOKUR Dividends paidOKUR Total assetsOKUR Total liabilitiesOKUR Shareholders’ equityOKUR overview →